{"id":19007,"date":"2024-04-16T11:34:09","date_gmt":"2024-04-16T09:34:09","guid":{"rendered":"https:\/\/adragos-pharma.com\/stimuler-la-croissance-grace-a-la-technologie-et-lexcellence-operationnelle\/"},"modified":"2025-07-11T10:38:15","modified_gmt":"2025-07-11T08:38:15","slug":"stimuler-la-croissance-technologie-et-excellence-operationnelle","status":"publish","type":"post","link":"https:\/\/adragos-pharma.com\/fr\/stimuler-la-croissance-technologie-et-excellence-operationnelle\/","title":{"rendered":"Stimuler la croissance : technologie et excellence op\u00e9rationnelle"},"content":{"rendered":"\n<p><a href=\"https:\/\/adragos-pharma.com\/fr\/notre-equipe\/andreas-raabe\/\">Notre PDG, Andreas Raabe<\/a>, a r\u00e9cemment discut\u00e9 de la croissance de notre entreprise et de nos objectifs strat\u00e9giques dans une interview avec Outsourcing Pharma. Il expose comment nous nous diff\u00e9rencions de nos concurrents et apportons de la valeur \u00e0 nos clients. <\/p>\n\n<p>Retrouvez l&rsquo;article complet ci-dessous.<\/p>\n\n<h2 class=\"wp-block-heading\">En conversation avec Andreas Raabe<\/h2>\n\n<p>Andreas Raabe, notre PDG, s&rsquo;est r\u00e9cemment entretenu avec Outsourcing Pharma au sujet de ses ambitions pour Adragos Pharma et de la valeur que nous apportons \u00e0 nos clients.<\/p>\n\n<p>Dans l&rsquo;interview, Raabe partage les d\u00e9tails de notre r\u00e9cente trajectoire de croissance qui souligne notre engagement \u00e0 \u00e9tendre notre empreinte de production sur les march\u00e9s cl\u00e9s en Europe, au Japon et en Am\u00e9rique du Nord. Il aborde \u00e9galement nos projets visant \u00e0 doubler ou tripler la taille de l&rsquo;entreprise dans les ann\u00e9es \u00e0 venir gr\u00e2ce \u00e0 des acquisitions strat\u00e9giques et \u00e0 une expansion organique. <\/p>\n\n<p>Raabe \u00e9voque aussi notre approche int\u00e9gr\u00e9e, offrant \u00e0 la fois des services de d\u00e9veloppement et de fabrication pour am\u00e9liorer l&rsquo;efficacit\u00e9 op\u00e9rationnelle de nos clients. Il met \u00e9galement en \u00e9vidence trois domaines cl\u00e9s qui distinguent Adragos de ses concurrents : <\/p>\n\n<ul class=\"wp-block-list\">\n<li>L&rsquo;exploitation de technologies de pointe<\/li>\n\n\n\n<li>La focalisation sur des mol\u00e9cules innovantes<\/li>\n\n\n\n<li>Un engagement envers l&rsquo;excellence op\u00e9rationnelle<\/li>\n<\/ul>\n\n<p>Enfin, Raabe d\u00e9taille notre engagement envers l&rsquo;ESG, partageant certaines des initiatives sur lesquelles nous avons travaill\u00e9 pour r\u00e9duire nos \u00e9missions de carbone.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Notre PDG, Andreas Raabe, a r\u00e9cemment discut\u00e9 de la croissance de notre entreprise et de nos objectifs strat\u00e9giques dans une interview avec Outsourcing Pharma. Il expose comment nous nous diff\u00e9rencions de nos concurrents et apportons de la valeur \u00e0 nos [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":6044,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","inline_featured_image":false,"footnotes":""},"categories":[185],"tags":[340,341,342,339],"topics":[44],"locations":[],"experts":[22],"class_list":["post-19007","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog","tag-andreas-raabe-fr","tag-entreprise","tag-externalisation-pharmaceutique","tag-gestion","topics-corporate","experts-dr-andreas-raabe"],"_links":{"self":[{"href":"https:\/\/adragos-pharma.com\/fr\/wp-json\/wp\/v2\/posts\/19007","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/adragos-pharma.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/adragos-pharma.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/adragos-pharma.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/adragos-pharma.com\/fr\/wp-json\/wp\/v2\/comments?post=19007"}],"version-history":[{"count":2,"href":"https:\/\/adragos-pharma.com\/fr\/wp-json\/wp\/v2\/posts\/19007\/revisions"}],"predecessor-version":[{"id":20310,"href":"https:\/\/adragos-pharma.com\/fr\/wp-json\/wp\/v2\/posts\/19007\/revisions\/20310"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/adragos-pharma.com\/fr\/wp-json\/wp\/v2\/media\/6044"}],"wp:attachment":[{"href":"https:\/\/adragos-pharma.com\/fr\/wp-json\/wp\/v2\/media?parent=19007"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/adragos-pharma.com\/fr\/wp-json\/wp\/v2\/categories?post=19007"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/adragos-pharma.com\/fr\/wp-json\/wp\/v2\/tags?post=19007"},{"taxonomy":"topics","embeddable":true,"href":"https:\/\/adragos-pharma.com\/fr\/wp-json\/wp\/v2\/topics?post=19007"},{"taxonomy":"locations","embeddable":true,"href":"https:\/\/adragos-pharma.com\/fr\/wp-json\/wp\/v2\/locations?post=19007"},{"taxonomy":"experts","embeddable":true,"href":"https:\/\/adragos-pharma.com\/fr\/wp-json\/wp\/v2\/experts?post=19007"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}